Skip to main content

LATEST NEWS

Recent Articles from TheStreet

Jim Cramer Reacts to the Procter & Gamble-Nelson Peltz Board Drama

Procter & Gamble Chart Looks Surprisingly Bullish After Earnings

Procter & Gamble stock is rallying after better-than-expected earnings. Here's how to trade it's surprisingly bullish setup now.

Google Lead

Google Might Soon Accept Crypto for Transactions

Tech and ad major Google wants to become the connective tissue for the entire consumer finance industry.

Donald Trump Lead

Trump Probe Finds 'Significant Evidence' of Fraud, New York AG Says

New York State Attorney General is seeking to question the former president and his two children.

Coca-Cola Lead

A Few Product Flops Later, Coca-Cola To Launch Mocha Version

Coca-Cola with Coffee Mocha reportedly "sips like a Coke and finishes like a coffee."

Contemporary Amperex Technology Co Ltd struck a two-year contract in February to supply batteries to Tesla, which produces its Model 3 electric cars at its Gigafactory in Shanghai. Photo: TNS

Electric Vehicle Checkpoint: Tesla Secures Plan-B For EV Batteries in Africa

See the latest news for the top stocks in the electric vehicle space including Ford, Lucid, Nio, Rivian and more.

Oil Prices Lead

Gasoline Prices at Multiyear High; Biden Scrambles to Lower Cost

Gasoline prices are the highest they've been in a decade as demand outpaces supply of crude.

SoFi Lead

Trading SoFi Stock as It Officially Becomes a Bank

SoFi Technologies has received regulatory approval to officially become a bank. Now here's how we're trading the stock.

18 shipping port sh

Supply Chain Woes: We're Not Out of the Woods Yet

A report from Everstream Analytics cites five ongoing risks, including ocean freight bottlenecks and increased regulation.

Housing Bubble

Will the U.S. Housing Market Crash in 2022?

Inflated prices and rising interest rates have people concerned that we could see a return of the 2008 housing crash.

Unilever Stock Rising on Possible Sir Kensington's Deal

Unilever Stock Surges After Brands Giant Says Won't Up $68 Billion GlaxoSmithKline Offer

Unilever said Wednesday that it won't increase its $68 billion offer for GlaxoSmithKline's healthcare division.